Saturday 17 October 2026
Export ELMD’s income statement to Excel — free account
Electromed, Inc.
ELMD Healthcare Medical Devices
Electromed, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $73.8 million, up 15.3% from fiscal 2025. In the quarter to June 2026, revenue grew 11.6%, EPS grew 57.7% and free cash flow fell 25.2%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.
27.42
0.61
−2.18%
Follow ELMD
| Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | Jun '25 | Jun '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 4 | 5 | 7 | 4 | 4 | 7 | 8 | 8 | 8 |
P/E ratio |
20.48 | 23.48 | 22.04 | 31.41 | 40.32 | 34.43 | 28.18 | 23.58 | 24.99 | 30.88 |
P/S ratio |
1.75 | 1.57 | 1.40 | 3.98 | 2.70 | 1.96 | 1.89 | 2.21 | 2.90 | 4.74 |
Altman Z-Score |
9.53 | 8.11 | 10.10 | 28.87 | 15.05 | 9.39 | 9.37 | 12.98 | 13.64 | 20.30 |
Altman Z″-Score (non-manufacturers) |
11.19 | 10.93 | 13.74 | 17.92 | 13.92 | 11.06 | 11.04 | 12.99 | 10.99 | 11.89 |
P/FCF ratio |
89.64 | 23.69 | 36.52 | 40.17 | 36.79 | 0.00 | 0.00 | 13.97 | 16.77 | 41.80 |
Beneish M-Score |
(2.07) | (2.56) | (2.34) | (2.33) | (2.38) | (1.99) | (2.17) | (2.79) | (2.76) | (2.20) |
P/Operating CF |
117.26 | 77.70 | 30.99 | 100.74 | 128.44 | (110.50) | 90.74 | 26.99 | 48.17 | 116.78 |
P/B ratio |
2.37 | 1.96 | 1.71 | 4.28 | 2.98 | 2.39 | 2.41 | 2.72 | 4.30 | 6.48 |
Price to Tangible BV |
2.46 | 2.02 | 1.75 | 4.36 | 3.05 | 2.43 | 2.45 | 2.76 | 4.34 | 6.52 |
EV/Sales |
1.58 | 1.38 | 1.19 | 3.70 | 2.40 | 1.79 | 1.76 | 1.94 | 2.68 | 4.48 |
EV/EBITDA |
9.39 | 11.13 | 9.91 | 20.48 | 22.92 | 20.73 | 18.27 | 14.31 | 15.55 | 22.09 |
EV/Operating CF |
34.21 | 15.99 | 14.38 | 28.60 | 27.93 | (108.81) | 64.19 | 11.71 | 15.08 | 34.18 |
EV/FCF |
80.86 | 20.88 | 30.95 | 37.28 | 32.69 | (33.76) | (210.50) | 12.25 | 15.49 | 39.49 |
Quick Ratio |
5.36 | 4.01 | 5.63 | 7.93 | 6.23 | 4.08 | 3.91 | 5.13 | 3.86 | 4.21 |
Current Ratio |
6.38 | 4.85 | 6.72 | 9.38 | 6.83 | 4.83 | 4.69 | 5.75 | 4.31 | 4.69 |
Net Debt/EBITDA |
(1.02) | (1.81) | (2.07) | (1.78) | (3.17) | (2.26) | (1.60) | (2.17) | (1.38) | (1.37) |
Debt/Assets |
4.98% | 4.02% | 0.10% | 0.22% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.06 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
1.19 | 1.12 | 1.10 | 1.04 | 1.02 | 1.06 | 1.10 | 1.12 | 1.21 | 1.23 |
Operating CF/Net income |
0.53 | 1.33 | 1.31 | 1.01 | 1.30 | (0.30) | 0.42 | 1.76 | 1.51 | 0.86 |
Capex/Depreciation |
(0.89) | (0.72) | (1.50) | (1.32) | (0.73) | (2.43) | (2.80) | (0.47) | (0.22) | (1.21) |
Interest Coverage |
71.53 | (136.30) | (31.20) | (42.30) | (116.30) | (118.88) | (51.38) | — | — | — |
| 12.59% | 8.79% | 8.20% | 14.86% | 7.54% | 6.92% | 8.81% | 12.53% | 17.18% | 23.26% | |
| 10.22% | 7.26% | 6.97% | 13.28% | 6.71% | 5.87% | 7.26% | 10.51% | 14.22% | 18.82% | |
ROIC |
15.24% | 10.44% | 9.85% | 16.12% | 9.56% | 7.14% | 8.27% | 14.45% | 21.62% | 25.87% |
Return on Tangible Assets |
11.81% | 8.49% | 8.09% | 14.44% | 7.70% | 7.21% | 8.94% | 12.36% | 19.16% | 22.44% |
Average Days of Receivables |
140.43 | 152.30 | 148.80 | 148.41 | 173.86 | 184.45 | 183.23 | 155.65 | 142.97 | 153.24 |
Research and Development Expense of Revenue |
2.31% | 0.89% | 1.86% | 3.23% | 4.82% | 3.25% | 1.91% | 1.20% | 1.56% | 1.78% |
Selling, General and Administrative Expense of Revenue |
63.42% | 66.45% | 65.29% | 61.42% | 62.77% | 65.09% | 65.73% | 63.03% | 61.43% | 57.94% |
Intangible Assets out of Total Assets |
0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Share Based Compensation of Revenue |
1.85% | 3.05% | 2.95% | 2.78% | 2.86% | 2.34% | 1.47% | 3.09% | 4.78% | 3.69% |
Graham Net Nets |
0.32 | 0.42 | 0.48 | 0.19 | 0.28 | 0.33 | 0.33 | 0.30 | 0.19 | 0.13 |
Graham Number |
3.77 | 3.77 | 4.09 | 6.30 | 4.88 | 5.04 | 6.17 | 8.38 | 10.06 | 14.19 |
Earnings Yield |
4.88% | 4.26% | 4.54% | 3.18% | 2.48% | 2.90% | 3.55% | 4.24% | 4.00% | 3.24% |
Free Cash Flow Yield |
1.12% | 4.22% | 2.74% | 2.49% | 2.72% | (2.71%) | (0.44%) | 7.16% | 5.96% | 2.39% |
Revenue per Share |
3.17 | 3.45 | 3.77 | 3.86 | 4.17 | 4.92 | 5.68 | 6.39 | 7.57 | 8.93 |
Operating CF per Share |
0.15 | 0.30 | 0.31 | 0.50 | 0.36 | (0.08) | 0.16 | 1.06 | 1.35 | 1.17 |
Capex per Share |
(0.08) | (0.07) | (0.17) | (0.12) | (0.05) | (0.18) | (0.20) | (0.05) | (0.04) | (0.16) |
Free Cash Flow per Share |
0.06 | 0.23 | 0.14 | 0.38 | 0.31 | (0.26) | (0.05) | 1.01 | 1.31 | 1.01 |
Cash per Share |
0.68 | 0.91 | 0.94 | 1.25 | 1.39 | 0.96 | 0.87 | 1.88 | 1.81 | 2.47 |
Shareholders Equity per Share |
2.33 | 2.75 | 3.10 | 3.60 | 3.78 | 4.03 | 4.45 | 5.20 | 5.11 | 6.53 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.33 | 2.75 | 3.10 | 3.60 | 3.78 | 4.03 | 4.45 | 5.20 | 5.11 | 6.53 |
Free Cash Flow |
0.50 | 1.87 | 1.20 | 3.22 | 2.63 | (2.21) | (0.40) | 8.67 | 11.09 | 8.37 |
Working Capital |
15.58 | 18.48 | 20.89 | 25.04 | 27.07 | 27.39 | 29.73 | 36.50 | 34.61 | 45.15 |
Capital Expenditures |
(0.69) | (0.57) | (1.39) | (0.98) | (0.45) | (1.52) | (1.72) | (0.39) | (0.31) | (1.30) |
Net Current Asset Value |
14.48 | 18.48 | 20.87 | 25.03 | 27.01 | 27.35 | 29.65 | 36.48 | 34.49 | 45.08 |
EV/EBIT |
11.41 | 14.40 | 13.16 | 23.45 | 27.37 | 25.12 | 21.06 | 16.14 | 17.78 | 23.80 |
Capex to Sales |
0.03 | 0.02 | 0.04 | 0.03 | 0.01 | 0.04 | 0.04 | 0.01 | 0.00 | 0.02 |
Price to Operating Income |
12.65 | 16.34 | 15.53 | 25.27 | 30.80 | 27.48 | 22.62 | 18.41 | 19.24 | 25.19 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.23 | 0.26 | 0.26 | 0.20 | 0.17 | 0.14 | 0.11 | 0.16 | 0.29 | 0.21 |
Cash ROIC |
1.95% | 6.01% | 3.58% | 7.89% | 5.93% | (5.22%) | (0.89%) | 14.30% | 18.95% | 11.24% |
Accounts Receivable Turnover |
2.91 | 2.60 | 2.55 | 2.50 | 2.37 | 2.19 | 2.13 | 2.31 | 2.64 | 2.63 |
Accounts Payable Turnover |
8.45 | 8.87 | 10.67 | 12.73 | 13.62 | 10.50 | 8.77 | 10.91 | 7.63 | 5.96 |
Inventory Turnover |
2.10 | 2.59 | 2.92 | 2.55 | 3.25 | 3.86 | 3.12 | 3.27 | 4.00 | 4.54 |
Average Days of Payables |
45.75 | 45.28 | 28.73 | 27.91 | 29.59 | 45.05 | 43.37 | 28.38 | 69.39 | 60.93 |
Days of Inventory on Hand |
176.51 | 138.91 | 128.43 | 154.87 | 91.30 | 113.53 | 133.41 | 104.30 | 85.83 | 84.86 |
Average Receivables |
8.88 | 10.88 | 12.29 | 12.98 | 15.12 | 19.04 | 22.59 | 23.73 | 24.20 | 28.02 |
Average Payables |
0.63 | 0.74 | 0.70 | 0.57 | 0.62 | 0.97 | 1.32 | 1.19 | 1.84 | 2.66 |
Average Inventory |
2.52 | 2.52 | 2.55 | 2.85 | 2.60 | 2.65 | 3.70 | 3.97 | 3.51 | 3.49 |
Average Assets |
21.82 | 25.23 | 28.40 | 31.32 | 35.18 | 39.24 | 43.59 | 49.02 | 53.02 | 60.03 |
Average Common Equity |
17.71 | 20.83 | 24.16 | 27.99 | 31.33 | 33.29 | 35.92 | 41.11 | 43.88 | 48.59 |
Columns are period end dates